Submit your Research to Nanovax 2025
October 10, 2024 – Ames, Iowa – The Nanovaccine Institute is pleased to announce the request for research and poster abstracts for Nanovax 2025: Next Generation Countermeasures for Emerging and Re-Emerging Disease. The conference will be held between April 2-3, 2025, in Ames, Iowa at the Gateway Hotel and Conference Center.
The global economy and trade of ecosystem services drive how humans and animals are interlinked, often dictating their health and resilience. Large-scale agricultural systems are necessary for food and energy, but current management practices lead to respiratory and chemical toxin exposure, and concentrations of animals and people. Given the dynamic nature of global pathogenic transmissibility, strains of respiratory diseases such as influenza, that may have once been confined endemically or partially controlled by vaccination within animals and people now have the capability to swathe entire regions and continents, resulting in pandemics. SARS-CoV-2 shined a light on weaknesses within public health but proved the ingenuity of biomedical research to produce, evaluate, and authorize a vaccine in under a year. The recent emergence of avian H5N1 within the livestock industry will be the next grand challenge to understand the biology of the disease and to develop existing and novel treatments to ensure global food security and to protect human populations.
The event will bring together experts from all corners of vaccine and therapeutic research to advance promising and robust next generation nanovaccines and nanotherapeutics through regulatory approvals and to clinical trials. The program will emphasize a transdisciplinary approach to transform the design and manufacturing of nanovaccines and nanotherapeutics that integrate nanotechnology, materials science, immunology, oncology, neuroscience, microbiology, clinical science, and social science.
The program committee also believes that innovative research is centered on early career development and training to foster the next generation of scientists. Programming will emphasize early career participation, mentorship, and high-impact research opportunities.
Presentation abstracts are due November 4, 2024, 5 PM Central Time.
Poster abstracts are due February 1, 2025, 5 PM Central Time.
Event Information: https://nanovaccine.iastate.edu/nanovax/